A New Way to Die: SADs
Dr. Rima Truth Reports, October 12, 2022

James Roguski interviews Dr. Rima about Sudden Adult Death Syndrome, SADs.

OBGYN Doctor Destroys Abortion Narrative in Congress
by Staff, September 30, 2022

At a Democrat-led hearing, a testifying doctor threw a monkey wrench in the panel’s goals. After an introduction, she opened with the words: "I’d like to discuss abortions’ harms to women and their children."

At the U.S. House Oversight and Reforms Committee, Prominent OB-GYN Dr. Monique Chireau Wubbenhorst told congress just how disastrous abortion is to its many victims.

"Abortion not only poses risk to the mother. It is always lethal to an unborn child," she said. Immediately framing the issue in a way that recognizes the unborn child as a human being worth of human rights. "It is my opinion that abortion is not health care." She went on to say clearly that the goal of abortion is "to kill the embryo or fetus, which is a human being."

She said that Dobbs v. Jackson is an opportunity to "mitigate abortion’s many harms to women in communities and to unborn human beings."

She directly and thoroughly undermines the argument that abortion is healthcare: "Abortion neither prevents, treats, or palliates any disease. It has instead as its goal the death of a human being. It is therefore not health care for the mother or her fetus, and research confirms this because the majority of OB-GYNs do not do abortions."

Read the full story  Pro Life Update

Gene-edited crops pioneer Calyxt crashes, giving the lie to deregulation claims
By Jonathan Matthews and Claire Robinson

There’s no evidence gene editing can rapidly bring desirable new crops to market.

As governments around the world are lobbied by industry with claims gene editing can deliver rapid solutions to our food and farming problems – they just need deregulation, the company that pioneered gene-edited crops in the lax regulatory environment of the US is considering selling its assets amid plummeting revenues and share prices.

Calyxt was the first to market gene-edited soybeans in 2019. The beans are genetically engineered to produce high oleic oil. You might think anyone wanting high oleic oils could just buy olive oil but Calyxt was primarily targeting the processed foods markets by promoting its oil as a healthier alternative to commodity soybean oils that produce trans fats when cooked at high temperatures, though no research directly showed health benefits.

Calyxt was also reported to have other "consumer-focused" gene-edited foods in the pipeline, like high fibre wheat and reduced browning potatoes.

Read the full story  GMWATCH